{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:30:24Z","timestamp":1761172224337,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.semerg.2020.12.003","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T01:19:29Z","timestamp":1611623969000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Foramen oval permeable. Una actualizaci\u00f3n para atenci\u00f3n primaria"],"prefix":"10.1016","volume":"47","author":[{"given":"C.","family":"Mart\u00edn Ma\u00f1ero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Medina Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Morales Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mart\u00edn Riobo\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2020.12.003_bib0235","doi-asserted-by":"crossref","first-page":"e007146","DOI":"10.1161\/JAHA.117.007146","article-title":"Patent foramen ovale closure for stroke prevention and other disorders","volume":"7","author":"Collado","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semerg.2020.12.003_bib0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"May Clin Proc"},{"key":"10.1016\/j.semerg.2020.12.003_bib0245","unstructured":"Defunciones seg\u00fan la causa de muerte 2018. Nota de prensa Instituto Nacional de Estad\u00edstica. Disponible en: https:\/\/www.ine.es\/prensa\/edcm_2018.pdf"},{"key":"10.1016\/j.semerg.2020.12.003_bib0250","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0300-8932(10)70090-7","article-title":"Prevalencia de foramen oval permeable diagnosticado mediante ecocardiograf\u00eda transesof\u00e1gica en pacientes de edad igual o mayor que 55 a\u00f1os con ictus criptog\u00e9nico. \u00bfEs diferente que en pacientes j\u00f3venes?","volume":"63","author":"Mesa","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0255","doi-asserted-by":"crossref","first-page":"e024144","DOI":"10.1136\/bmjopen-2018-024144","article-title":"Relationship between right-to-left shunt and migraine in patients with epilepsy: A single-centre, cross-sectional study in China","volume":"8","author":"Zhang","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.semerg.2020.12.003_bib0260","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/head.12779","article-title":"Patent foramen ovale and migraine: Closing the debate\u2013a review","volume":"56","author":"Tariq","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.semerg.2020.12.003_bib0265","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/STROKEAHA.117.020160","article-title":"Frequency of patent foramen ovale and migraine in patients with cryptogenic stroke","volume":"49","author":"West","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.semerg.2020.12.003_bib0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00015385.2018.1475027","article-title":"Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine","volume":"74","author":"Elbadawi","year":"2019","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12872-017-0644-9","article-title":"Migraine and percutaneous patent foramen ovale closure: A systematic review and meta-analysis","volume":"17","author":"Shi","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.semerg.2020.12.003_bib0280","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jcin.2012.03.013","article-title":"The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache","volume":"5","author":"Khessali","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.semerg.2020.12.003_bib0285","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mehy.2016.07.003","article-title":"Is oral contraceptive-induced headache dependent on patent foramen ovale? Clinical dynamics, evidence-based hypothesis and possible patient-oriented management","volume":"94","author":"Chiofalo","year":"2016","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.semerg.2020.12.003_bib0290","article-title":"Diagnosis of patent foramen ovale: The combination of contrast transcranial Doppler contrast transthoracic echocardiography, and contrast transesophageal echocardiography","volume":"2020","author":"Yang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.semerg.2020.12.003_bib0295","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/svn-2018-000173","article-title":"Patent foramen ovale and cryptogenic stroke: Diagnosis and updates in secondary stroke prevention","volume":"3","author":"Yuan","year":"2018","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0300","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/eurheartj\/ehy649","article-title":"European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism","volume":"40","author":"Pristipino","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2020.12.003_bib0305","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.echo.2019.03.021","article-title":"Identification of high-risk patent foramen ovale associated with cryptogenic stroke: Development of a scoring system","volume":"32","author":"Nakayama","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.semerg.2020.12.003_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000506433","article-title":"Morphomteric features of patent foraman ovale as a risk factor of cerebrovascular accidents: A systemtic review and meta-analysis","volume":"49","author":"Holda","year":"2020","journal-title":"Cerebrovascular Dis"},{"key":"10.1016\/j.semerg.2020.12.003_bib0315","first-page":"47","article-title":"A debate: Cierre del foramen oval permeable. Perspectiva del cardi\u00f3logo intervencionista","volume":"1","author":"Hernandez","year":"2020","journal-title":"REC Interv Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0320","first-page":"44","article-title":"A debate: cierre del foramen oval permeable. Perspectiva del neur\u00f3logo","volume":"1","author":"Serena","year":"2020","journal-title":"REC Interv Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0325","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2020.12.003_bib0330","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2020.12.003_bib0335","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-Term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semerg.2020.12.003_bib0340","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0345","doi-asserted-by":"crossref","first-page":"e008356","DOI":"10.1161\/JAHA.117.008356","article-title":"Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: Systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE study","volume":"7","author":"Turc","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.semerg.2020.12.003_bib0350","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","article-title":"Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: Updated systematic review and meta-analysis","volume":"49","author":"Ntaios","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.semerg.2020.12.003_bib0355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00392-018-1334-z","article-title":"Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: Updated meta-analysis","volume":"108","author":"Vukadinovi\u0107","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0360","first-page":"176","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials","volume":"92","author":"Abdelaziz","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.semerg.2020.12.003_bib0365","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00392-018-1246-y","article-title":"Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: Updated meta-analysis of randomized clinical trials","volume":"107","author":"Alushi","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0370","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/sni.sni_111_18","article-title":"Management of patent foramen ovale in patients with cryptogenic stroke: Is device closure superior to medical treatment? A brief review","volume":"9","author":"Sidia","year":"2018","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.semerg.2020.12.003_bib0375","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M17-2679","article-title":"Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: A systematic review and meta-analysis","volume":"168","author":"Shah","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semerg.2020.12.003_bib0380","first-page":"165","article-title":"Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials","volume":"92","author":"Akobeng","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.semerg.2020.12.003_bib0385","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/M17-3033","article-title":"Percutaneous closureversus medical treatment in stroke patients with patent foramen ovale a systematic review and meta-analysis","volume":"168","author":"De Rosa","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semerg.2020.12.003_bib0390","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.hlc.2018.02.023","article-title":"Patent foramen ovale closure versus medical therapy for cryptogenic stroke: Meta-analysis of randomised trials","volume":"28","author":"Wang","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.semerg.2020.12.003_bib0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.hlc.2013.12.003","article-title":"Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: A meta-analysis of randomised trials","volume":"23","author":"Pandit","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.semerg.2020.12.003_bib0400","first-page":"531","article-title":"El cierre del foramen oval permeable en pacientes con ictus isqu\u00e9mico de origen criptog\u00e9nico: un camino de resultados negativos y positivos","volume":"3","author":"Cruz","year":"2018","journal-title":"JONNPR"},{"key":"10.1016\/j.semerg.2020.12.003_bib0405","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"issue":"12 Suppl X","key":"10.1016\/j.semerg.2020.12.003_bib0410","doi-asserted-by":"crossref","first-page":"X7","DOI":"10.4244\/EIJV12SXA2","article-title":"Patent foramen ovale: Indications for closure and techniques","volume":"17","author":"Taramasso","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.semerg.2020.12.003_bib0415","doi-asserted-by":"crossref","first-page":"e18675","DOI":"10.1097\/MD.0000000000018675","article-title":"Long-term efficacy after closure of patent foramen ovale for ischemic neurological events in young adults: A systematic review and meta-analysis","volume":"99","author":"Xu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semerg.2020.12.003_bib0420","doi-asserted-by":"crossref","first-page":"e023761","DOI":"10.1136\/bmjopen-2018-023761","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: A systematic review and network meta-analysis incorporating complementary external evidence","volume":"8","author":"Mir","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.semerg.2020.12.003_bib0425","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2018.10.061","article-title":"Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism cryptogenic embolism","volume":"73","author":"Wintzer-Wehekind","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0430","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.amjcard.2019.01.043","article-title":"Impact of discontinuation of antithrombotic therapy following closure of patent foramen ovale in patients with cryptogenic embolism","volume":"123","author":"Wintzer-Wehekind","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0435","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fcvm.2019.00075","article-title":"Antithrombotic\/antiplatelet treatment in transcatheter structural cardiac interventions\u2014pfo\/asd\/laa occluder and interatrial shunt devices","volume":"6","author":"Olasinska-Wisniewska","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.semerg.2020.12.003_bib0440","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1161\/STROKEAHA.119.026512","article-title":"Antithrombotic treatment in cryptogenic stroke patients with patent foramen ovale: Systematic review and meta-analysis","volume":"50","author":"Sagris","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.semerg.2020.12.003_bib0445","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejim.2019.12.010","article-title":"Light anti-thrombotic regimen for prevention of device thrombosis and\/or thrombotic complications after interatrial shunts device-based closure","volume":"74","author":"Rigatelli","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.semerg.2020.12.003_bib0450","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s10072-020-04388-4","article-title":"Aspirin or anticoagulation after cryptogenic stroke with patent foramen ovalle: Sistematic review and meta-analysis of randomized controlled trials","volume":"41","author":"Romoli","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.semerg.2020.12.003_bib0455","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.recesp.2018.10.015","article-title":"Ictus criptogen\u00e9tico con foramen oval permeable. \u00bfCu\u00e1ndo se debe cerrar?","volume":"72","author":"Madhkour","year":"2019","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.semerg.2020.12.003_bib0460","unstructured":"Pinto S, Nunes A, Santos C, Kasner SE, Nunes J PL. The role of patent foramen ovale closure in the secondary prevention of cryptogenic stroke: A meta-analysis report. Int J Cardiovasc Sci. 2020;33(4):307-17."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359320304123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359320304123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:40:19Z","timestamp":1761108019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359320304123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1138359320304123"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2020.12.003","relation":{},"ISSN":["1138-3593"],"issn-type":[{"type":"print","value":"1138-3593"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Foramen oval permeable. Una actualizaci\u00f3n para atenci\u00f3n primaria","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2020.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}